A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : FLT3

Search Conditions:
Search Keyword : FLT3
Search Method : Exact match.
Research Area:

Abbreviation: FLT3
Appearance Frequency: 801 time(s)
Long forms: 21

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
FMS-like tyrosine kinase 3
(602 times)
(198 times)
AML (389 times)
ITD (147 times)
TKD (36 times)
1999 Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
fms-related tyrosine kinase 3
(99 times)
(46 times)
AML (75 times)
ITD (27 times)
OS (9 times)
2003 Resistance to spontaneous apoptosis in acute myeloid leukaemia blasts is associated with p-glycoprotein expression and function, but not with the presence of FLT3 internal tandem duplications.
(37 times)
(14 times)
AML (26 times)
AR (2 times)
FLT3-TKD (2 times)
2006 Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
FMS-like receptor tyrosine kinase-3
(17 times)
(7 times)
AML (11 times)
ITD (3 times)
ALL (2 times)
2005 Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
(16 times)
(9 times)
AML (10 times)
ITD (8 times)
CR (3 times)
2003 SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo.
foetal liver tyrosine kinase 3
(10 times)
(5 times)
AML (9 times)
ASCT (2 times)
CR (2 times)
2005 No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.
(3 times)
(3 times)
AML (3 times)
ITD (2 times)
TKD (2 times)
2003 FLT3-TKD mutation in childhood acute myeloid leukemia.
Fms-like tyrosine receptor kinase 3
(3 times)
(2 times)
AML (2 times)
FLT3-ITD (1 time)
2019 Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia.
feline mcDonough sarcoma-like tyrosine kinase 3
(2 times)
(1 time)
AML (1 time)
CAR (1 time)
I/R (1 time)
2020 Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid Leukemia.
10  Famus like tyrosine kinase-3
(1 time)
Genetics, Medical
(1 time)
AML (1 time)
APL (1 time)
NPM1 (1 time)
2014 FLT3 and NPM-1 mutations in a cohort of acute promyelocytic leukemia patients from India.
11  fibromyalgia syndrome-like tyrosine kinase 3
(1 time)
Allergy and Immunology
(1 time)
HPCs (1 time)
NK (1 time)
2013 Axl/Gas6 pathway positively regulates FLT3 activation in human natural killer cell development.
12  flt3 receptor gene
(1 time)
(1 time)
AML (1 time)
AML/TMDS (1 time)
MDS (1 time)
1997 Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia.
13  FLT3 receptor tyrosine kinase
(1 time)
Cell Biology
(1 time)
HSCs (1 time)
2001 The FLT3 tyrosine kinase receptor inhibits neural stem/progenitor cell proliferation and collaborates with NGF to promote neuronal survival.
14  FLT3 tyrosine kinase receptor
(1 time)
(1 time)
NT-3 (1 time)
2005 Neurotrophin-3 and FLT3 tyrosine kinase receptor in perinatal life.
15  FLT3-840GS
(1 time)
(1 time)
AML (1 time)
JM (1 time)
PTK (1 time)
2002 A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia.
16  FLT3-ITD, FLT3-N841I, and FLT3-D835V
(1 time)
Chemistry, Pharmaceutical
(1 time)
AML (1 time)
2016 Discovery of a Highly Potent and Selective Indenoindolone Type 1 Pan-FLT3 Inhibitor.
17  FLT3-JM-PMs
(1 time)
(1 time)
AML (1 time)
FLT3-ITDs (1 time)
FLT3-TKD (1 time)
2006 Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML.
18  FLT3-WT and FLT3-ITD
(1 time)
(1 time)
--- 2016 FMS-like tyrosine kinase 3 (FLT3) inhibitors: Molecular docking and experimental studies.
19  FLT3/FLK2
(1 time)
(1 time)
BM (1 time)
BTU-E (1 time)
CAFC (1 time)
1997 Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
20  Fms related RTK 3
(1 time)
MERTK (1 time)
RTKIs (1 time)
TCR (1 time)
2021 Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8+ T Cells.
21  Fms-like tyrosine-3
(1 time)
(1 time)
allo-SCT (1 time)
AML (1 time)
ITD (1 time)
2009 Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation.